

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.89543903 |
| 2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.54214474 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 5.54214474 |
| 4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.94732079 |
| 5 | proteasome assembly (GO:0043248) | 4.89526659 |
| 6 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.87843200 |
| 7 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.87843200 |
| 8 | NADH dehydrogenase complex assembly (GO:0010257) | 4.87843200 |
| 9 | protein complex biogenesis (GO:0070271) | 4.84870640 |
| 10 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.58928112 |
| 11 | respiratory electron transport chain (GO:0022904) | 4.55928784 |
| 12 | oxidative phosphorylation (GO:0006119) | 4.47034923 |
| 13 | electron transport chain (GO:0022900) | 4.45589036 |
| 14 | regulation of mitochondrial translation (GO:0070129) | 4.39590520 |
| 15 | cullin deneddylation (GO:0010388) | 4.21093863 |
| 16 | ribosomal small subunit assembly (GO:0000028) | 4.20357419 |
| 17 | chaperone-mediated protein transport (GO:0072321) | 4.15361479 |
| 18 | protein deneddylation (GO:0000338) | 4.14750738 |
| 19 | termination of RNA polymerase III transcription (GO:0006386) | 4.12929833 |
| 20 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.12929833 |
| 21 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.08717422 |
| 22 | DNA deamination (GO:0045006) | 4.08708184 |
| 23 | protein neddylation (GO:0045116) | 4.03966197 |
| 24 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.01527246 |
| 25 | 7-methylguanosine mRNA capping (GO:0006370) | 4.00763076 |
| 26 | 7-methylguanosine RNA capping (GO:0009452) | 3.92872848 |
| 27 | RNA capping (GO:0036260) | 3.92872848 |
| 28 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.83470960 |
| 29 | rRNA modification (GO:0000154) | 3.79776988 |
| 30 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.78557639 |
| 31 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.78236342 |
| 32 | respiratory chain complex IV assembly (GO:0008535) | 3.77370397 |
| 33 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.75840230 |
| 34 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.74807511 |
| 35 | negative regulation of ligase activity (GO:0051352) | 3.72254057 |
| 36 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.72254057 |
| 37 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.71310618 |
| 38 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.71310618 |
| 39 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.70335533 |
| 40 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.70208945 |
| 41 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.70208945 |
| 42 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.70208945 |
| 43 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.69342076 |
| 44 | maturation of SSU-rRNA (GO:0030490) | 3.62334409 |
| 45 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.59761234 |
| 46 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.59320420 |
| 47 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.59320420 |
| 48 | cytochrome complex assembly (GO:0017004) | 3.56261708 |
| 49 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.54359987 |
| 50 | aerobic respiration (GO:0009060) | 3.54193023 |
| 51 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.51629754 |
| 52 | branched-chain amino acid catabolic process (GO:0009083) | 3.51627035 |
| 53 | ribosomal small subunit biogenesis (GO:0042274) | 3.47910864 |
| 54 | protein targeting to mitochondrion (GO:0006626) | 3.45854293 |
| 55 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.45192065 |
| 56 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.45192065 |
| 57 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.42528573 |
| 58 | establishment of integrated proviral latency (GO:0075713) | 3.41104469 |
| 59 | establishment of protein localization to mitochondrion (GO:0072655) | 3.40788624 |
| 60 | cellular component biogenesis (GO:0044085) | 3.40590695 |
| 61 | pseudouridine synthesis (GO:0001522) | 3.39925947 |
| 62 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.37704867 |
| 63 | formation of translation preinitiation complex (GO:0001731) | 3.34603074 |
| 64 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.32645488 |
| 65 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.30418984 |
| 66 | nucleobase biosynthetic process (GO:0046112) | 3.30269459 |
| 67 | purine nucleobase biosynthetic process (GO:0009113) | 3.29174692 |
| 68 | L-methionine salvage (GO:0071267) | 3.28611306 |
| 69 | L-methionine biosynthetic process (GO:0071265) | 3.28611306 |
| 70 | amino acid salvage (GO:0043102) | 3.28611306 |
| 71 | termination of RNA polymerase I transcription (GO:0006363) | 3.28184073 |
| 72 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.27605686 |
| 73 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.26432803 |
| 74 | rRNA methylation (GO:0031167) | 3.26429848 |
| 75 | telomere maintenance via recombination (GO:0000722) | 3.25791692 |
| 76 | positive regulation of ligase activity (GO:0051351) | 3.23146395 |
| 77 | ribosomal large subunit biogenesis (GO:0042273) | 3.22033253 |
| 78 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.21282839 |
| 79 | translation (GO:0006412) | 3.20578339 |
| 80 | transcription from RNA polymerase I promoter (GO:0006360) | 3.19693069 |
| 81 | GTP biosynthetic process (GO:0006183) | 3.18644363 |
| 82 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.17517166 |
| 83 | protein localization to mitochondrion (GO:0070585) | 3.15303983 |
| 84 | DNA strand elongation (GO:0022616) | 3.11952664 |
| 85 | viral transcription (GO:0019083) | 3.09974372 |
| 86 | ribosome biogenesis (GO:0042254) | 3.08654256 |
| 87 | ATP biosynthetic process (GO:0006754) | 3.08364810 |
| 88 | peptidyl-histidine modification (GO:0018202) | 3.07983857 |
| 89 | translational termination (GO:0006415) | 3.07830276 |
| 90 | intracellular protein transmembrane import (GO:0044743) | 3.07058715 |
| 91 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.05984322 |
| 92 | platelet dense granule organization (GO:0060155) | 3.05510701 |
| 93 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.04698914 |
| 94 | CENP-A containing nucleosome assembly (GO:0034080) | 3.01161796 |
| 95 | DNA replication checkpoint (GO:0000076) | 3.00782459 |
| 96 | hydrogen ion transmembrane transport (GO:1902600) | 3.00356710 |
| 97 | rRNA processing (GO:0006364) | 3.00121028 |
| 98 | DNA replication initiation (GO:0006270) | 2.98194888 |
| 99 | ubiquinone metabolic process (GO:0006743) | 2.96548456 |
| 100 | protein-cofactor linkage (GO:0018065) | 2.96369669 |
| 101 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.94205608 |
| 102 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.94020526 |
| 103 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.93900498 |
| 104 | cotranslational protein targeting to membrane (GO:0006613) | 2.93608252 |
| 105 | maturation of 5.8S rRNA (GO:0000460) | 2.93048752 |
| 106 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.92911831 |
| 107 | DNA damage response, detection of DNA damage (GO:0042769) | 2.91762264 |
| 108 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.91623484 |
| 109 | spliceosomal snRNP assembly (GO:0000387) | 2.90803345 |
| 110 | positive regulation of cell cycle arrest (GO:0071158) | 2.90474355 |
| 111 | mitochondrial transport (GO:0006839) | 2.90185956 |
| 112 | viral mRNA export from host cell nucleus (GO:0046784) | 2.89380588 |
| 113 | translational elongation (GO:0006414) | 2.88906818 |
| 114 | chromatin remodeling at centromere (GO:0031055) | 2.86674176 |
| 115 | inositol phosphate catabolic process (GO:0071545) | 2.86264607 |
| 116 | proton transport (GO:0015992) | 2.81616262 |
| 117 | anterograde synaptic vesicle transport (GO:0048490) | 2.81278641 |
| 118 | mannosylation (GO:0097502) | 2.79844933 |
| 119 | DNA double-strand break processing (GO:0000729) | 2.78258304 |
| 120 | hydrogen transport (GO:0006818) | 2.75983695 |
| 121 | lactate metabolic process (GO:0006089) | 2.72493280 |
| 122 | regulation of hexokinase activity (GO:1903299) | 2.67056941 |
| 123 | regulation of glucokinase activity (GO:0033131) | 2.67056941 |
| 124 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.65405029 |
| 125 | inner mitochondrial membrane organization (GO:0007007) | 2.65382126 |
| 126 | inositol phosphate dephosphorylation (GO:0046855) | 2.64947249 |
| 127 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.64947249 |
| 128 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.64535045 |
| 129 | branched-chain amino acid metabolic process (GO:0009081) | 2.63293787 |
| 130 | protein K11-linked ubiquitination (GO:0070979) | 2.62193136 |
| 131 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.60448257 |
| 132 | ubiquinone biosynthetic process (GO:0006744) | 2.58515944 |
| 133 | synapsis (GO:0007129) | 2.58134433 |
| 134 | intraciliary transport (GO:0042073) | 2.56273064 |
| 135 | histone exchange (GO:0043486) | 2.53503691 |
| 136 | histone H2A acetylation (GO:0043968) | 2.52271727 |
| 137 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.51477041 |
| 138 | piRNA metabolic process (GO:0034587) | 2.47326771 |
| 139 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.47010850 |
| 140 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.47010850 |
| 141 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.42666946 |
| 142 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.41700190 |
| 143 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.41700190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.98416370 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.44372532 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.11925245 |
| 4 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.08422823 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.04862041 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.97773306 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.92646040 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.76655369 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.47973123 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.26787254 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.25880956 |
| 12 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.17589553 |
| 13 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.12222867 |
| 14 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 3.10620802 |
| 15 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.97061407 |
| 16 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.78185913 |
| 17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.74413105 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.74318632 |
| 19 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.68055735 |
| 20 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.61027414 |
| 21 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.50671176 |
| 22 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.50029274 |
| 23 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.41842249 |
| 24 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.38995094 |
| 25 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.37205050 |
| 26 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.34617674 |
| 27 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.30791524 |
| 28 | VDR_22108803_ChIP-Seq_LS180_Human | 2.25474176 |
| 29 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.25353405 |
| 30 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.25017332 |
| 31 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.21633179 |
| 32 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.21049715 |
| 33 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.15711790 |
| 34 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.09341090 |
| 35 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.06442774 |
| 36 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.04458034 |
| 37 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.02430927 |
| 38 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.99549212 |
| 39 | EWS_26573619_Chip-Seq_HEK293_Human | 1.98285765 |
| 40 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.98266859 |
| 41 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.95600250 |
| 42 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.94149113 |
| 43 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.92312051 |
| 44 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.86894294 |
| 45 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.85611813 |
| 46 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82427249 |
| 47 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.80831636 |
| 48 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.79159746 |
| 49 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.76208806 |
| 50 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.75983399 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74402317 |
| 52 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.66591716 |
| 53 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.63767247 |
| 54 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.52769254 |
| 55 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.50937308 |
| 56 | P300_19829295_ChIP-Seq_ESCs_Human | 1.50055269 |
| 57 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.46967613 |
| 58 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.46095684 |
| 59 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.45406776 |
| 60 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.42588750 |
| 61 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.41932098 |
| 62 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39469947 |
| 63 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.37172462 |
| 64 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.35639897 |
| 65 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34351248 |
| 66 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.32207122 |
| 67 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.31249550 |
| 68 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.30455744 |
| 69 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.29834652 |
| 70 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.26152037 |
| 71 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.24505105 |
| 72 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.21624100 |
| 73 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.21436007 |
| 74 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.20694984 |
| 75 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.20119978 |
| 76 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.19925822 |
| 77 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.19904129 |
| 78 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.19227513 |
| 79 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.19152085 |
| 80 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.19152085 |
| 81 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.17628224 |
| 82 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16102031 |
| 83 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.15342251 |
| 84 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15255370 |
| 85 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.14635112 |
| 86 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.13532810 |
| 87 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11076848 |
| 88 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.10636275 |
| 89 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.10350667 |
| 90 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.09804845 |
| 91 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09445675 |
| 92 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.09041017 |
| 93 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.09041017 |
| 94 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.08261368 |
| 95 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.06333110 |
| 96 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.04516958 |
| 97 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02920408 |
| 98 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01979255 |
| 99 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.01841984 |
| 100 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.01803753 |
| 101 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.01501834 |
| 102 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.01096800 |
| 103 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.01096800 |
| 104 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.01086605 |
| 105 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.00524568 |
| 106 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.99113181 |
| 107 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.98673084 |
| 108 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97662449 |
| 109 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.97631602 |
| 110 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.97568339 |
| 111 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.97335961 |
| 112 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.97056440 |
| 113 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.96967851 |
| 114 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.96451463 |
| 115 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.95766067 |
| 116 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.94892295 |
| 117 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.94723855 |
| 118 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.94269634 |
| 119 | AR_20517297_ChIP-Seq_VCAP_Human | 0.94005348 |
| 120 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.93997335 |
| 121 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.92806745 |
| 122 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.90502851 |
| 123 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.90272824 |
| 124 | AR_25329375_ChIP-Seq_VCAP_Human | 0.89635663 |
| 125 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.89314109 |
| 126 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.87492821 |
| 127 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.87315105 |
| 128 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.87156677 |
| 129 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.87052561 |
| 130 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.87050928 |
| 131 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.84805604 |
| 132 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.83051041 |
| 133 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.79593004 |
| 134 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.78798125 |
| 135 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.78143299 |
| 136 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.77057962 |
| 137 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.75302671 |
| 138 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73279727 |
| 139 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.71860491 |
| 140 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.71765609 |
| 141 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.70984425 |
| 142 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.70680438 |
| 143 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.70185149 |
| 144 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.70026506 |
| 145 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.69433690 |
| 146 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.69282183 |
| 147 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.68535135 |
| 148 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.68243742 |
| 149 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.68069758 |
| 150 | FUS_26573619_Chip-Seq_HEK293_Human | 0.68066397 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.09744878 |
| 2 | MP0001529_abnormal_vocalization | 3.31174259 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 3.24319004 |
| 4 | MP0010094_abnormal_chromosome_stability | 3.15094303 |
| 5 | MP0004957_abnormal_blastocyst_morpholog | 3.00525415 |
| 6 | MP0008058_abnormal_DNA_repair | 3.00400173 |
| 7 | MP0001986_abnormal_taste_sensitivity | 2.99020682 |
| 8 | MP0006036_abnormal_mitochondrial_physio | 2.97664849 |
| 9 | MP0003646_muscle_fatigue | 2.97042881 |
| 10 | MP0008057_abnormal_DNA_replication | 2.80393320 |
| 11 | MP0006072_abnormal_retinal_apoptosis | 2.56004210 |
| 12 | MP0003077_abnormal_cell_cycle | 2.39390194 |
| 13 | MP0003111_abnormal_nucleus_morphology | 2.37235223 |
| 14 | MP0003718_maternal_effect | 2.34029237 |
| 15 | MP0006035_abnormal_mitochondrial_morpho | 2.26829233 |
| 16 | MP0003195_calcinosis | 2.22209195 |
| 17 | MP0003186_abnormal_redox_activity | 2.14522844 |
| 18 | MP0009697_abnormal_copulation | 2.13339756 |
| 19 | MP0008877_abnormal_DNA_methylation | 2.10347161 |
| 20 | MP0002837_dystrophic_cardiac_calcinosis | 2.09416890 |
| 21 | MP0001905_abnormal_dopamine_level | 2.01901754 |
| 22 | MP0004145_abnormal_muscle_electrophysio | 1.97382696 |
| 23 | MP0008932_abnormal_embryonic_tissue | 1.96436253 |
| 24 | MP0003786_premature_aging | 1.95505723 |
| 25 | MP0002163_abnormal_gland_morphology | 1.89334993 |
| 26 | MP0005075_abnormal_melanosome_morpholog | 1.74517471 |
| 27 | MP0005253_abnormal_eye_physiology | 1.74465977 |
| 28 | MP0006292_abnormal_olfactory_placode | 1.73377550 |
| 29 | MP0002132_abnormal_respiratory_system | 1.73372854 |
| 30 | MP0008260_abnormal_autophagy | 1.71019354 |
| 31 | MP0001188_hyperpigmentation | 1.70369190 |
| 32 | MP0001764_abnormal_homeostasis | 1.69076402 |
| 33 | MP0009379_abnormal_foot_pigmentation | 1.68365435 |
| 34 | MP0001984_abnormal_olfaction | 1.60881450 |
| 35 | MP0008789_abnormal_olfactory_epithelium | 1.58299993 |
| 36 | MP0006276_abnormal_autonomic_nervous | 1.56781546 |
| 37 | MP0000372_irregular_coat_pigmentation | 1.56180241 |
| 38 | MP0008007_abnormal_cellular_replicative | 1.55691740 |
| 39 | MP0004142_abnormal_muscle_tone | 1.54916349 |
| 40 | MP0005551_abnormal_eye_electrophysiolog | 1.51212909 |
| 41 | MP0005645_abnormal_hypothalamus_physiol | 1.51069925 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.50828761 |
| 43 | MP0010386_abnormal_urinary_bladder | 1.44709433 |
| 44 | MP0003123_paternal_imprinting | 1.43283763 |
| 45 | MP0002736_abnormal_nociception_after | 1.43086038 |
| 46 | MP0005084_abnormal_gallbladder_morpholo | 1.41778016 |
| 47 | MP0003136_yellow_coat_color | 1.40666968 |
| 48 | MP0005379_endocrine/exocrine_gland_phen | 1.39716994 |
| 49 | MP0005266_abnormal_metabolism | 1.38514363 |
| 50 | MP0002638_abnormal_pupillary_reflex | 1.37630417 |
| 51 | MP0000749_muscle_degeneration | 1.35590897 |
| 52 | MP0005332_abnormal_amino_acid | 1.31655289 |
| 53 | MP0003880_abnormal_central_pattern | 1.30176576 |
| 54 | MP0002090_abnormal_vision | 1.28757414 |
| 55 | MP0004084_abnormal_cardiac_muscle | 1.27484398 |
| 56 | MP0004215_abnormal_myocardial_fiber | 1.26957602 |
| 57 | MP0003137_abnormal_impulse_conducting | 1.26679615 |
| 58 | MP0003890_abnormal_embryonic-extraembry | 1.26285640 |
| 59 | MP0005670_abnormal_white_adipose | 1.24263637 |
| 60 | MP0001485_abnormal_pinna_reflex | 1.24259134 |
| 61 | MP0002102_abnormal_ear_morphology | 1.22918102 |
| 62 | MP0001835_abnormal_antigen_presentation | 1.21238548 |
| 63 | MP0002234_abnormal_pharynx_morphology | 1.21235386 |
| 64 | MP0005187_abnormal_penis_morphology | 1.18865369 |
| 65 | MP0004147_increased_porphyrin_level | 1.18442699 |
| 66 | MP0009785_altered_susceptibility_to | 1.17049318 |
| 67 | MP0000358_abnormal_cell_content/ | 1.14916964 |
| 68 | MP0009046_muscle_twitch | 1.14510167 |
| 69 | MP0008995_early_reproductive_senescence | 1.14245985 |
| 70 | MP0003122_maternal_imprinting | 1.13425588 |
| 71 | MP0005671_abnormal_response_to | 1.12047652 |
| 72 | MP0005394_taste/olfaction_phenotype | 1.10874469 |
| 73 | MP0005499_abnormal_olfactory_system | 1.10874469 |
| 74 | MP0004036_abnormal_muscle_relaxation | 1.09974667 |
| 75 | MP0002332_abnormal_exercise_endurance | 1.09554207 |
| 76 | MP0002148_abnormal_hypersensitivity_rea | 1.09172578 |
| 77 | MP0002909_abnormal_adrenal_gland | 1.06067863 |
| 78 | MP0003567_abnormal_fetal_cardiomyocyte | 1.03310283 |
| 79 | MP0003787_abnormal_imprinting | 1.02828373 |
| 80 | MP0001853_heart_inflammation | 1.02657170 |
| 81 | MP0000015_abnormal_ear_pigmentation | 1.01380600 |
| 82 | MP0000049_abnormal_middle_ear | 1.00093649 |
| 83 | MP0002822_catalepsy | 0.98995018 |
| 84 | MP0005451_abnormal_body_composition | 0.97921908 |
| 85 | MP0001968_abnormal_touch/_nociception | 0.96841027 |
| 86 | MP0004133_heterotaxia | 0.95980355 |
| 87 | MP0000490_abnormal_crypts_of | 0.95841259 |
| 88 | MP0005376_homeostasis/metabolism_phenot | 0.95812126 |
| 89 | MP0009745_abnormal_behavioral_response | 0.95293378 |
| 90 | MP0005620_abnormal_muscle_contractility | 0.95077726 |
| 91 | MP0003221_abnormal_cardiomyocyte_apopto | 0.94600950 |
| 92 | MP0000013_abnormal_adipose_tissue | 0.92752098 |
| 93 | MP0009333_abnormal_splenocyte_physiolog | 0.92268871 |
| 94 | MP0002210_abnormal_sex_determination | 0.91849070 |
| 95 | MP0002972_abnormal_cardiac_muscle | 0.90851223 |
| 96 | MP0004085_abnormal_heartbeat | 0.90248718 |
| 97 | MP0001293_anophthalmia | 0.89866484 |
| 98 | MP0002160_abnormal_reproductive_system | 0.89196170 |
| 99 | MP0000631_abnormal_neuroendocrine_gland | 0.88157894 |
| 100 | MP0000647_abnormal_sebaceous_gland | 0.87387981 |
| 101 | MP0005171_absent_coat_pigmentation | 0.87005435 |
| 102 | MP0004270_analgesia | 0.85137298 |
| 103 | MP0003950_abnormal_plasma_membrane | 0.83330996 |
| 104 | MP0002734_abnormal_mechanical_nocicepti | 0.82564702 |
| 105 | MP0002876_abnormal_thyroid_physiology | 0.82039628 |
| 106 | MP0000313_abnormal_cell_death | 0.81930054 |
| 107 | MP0000751_myopathy | 0.81393973 |
| 108 | MP0002735_abnormal_chemical_nociception | 0.80936722 |
| 109 | MP0005389_reproductive_system_phenotype | 0.79537846 |
| 110 | MP0005636_abnormal_mineral_homeostasis | 0.79102038 |
| 111 | MP0005330_cardiomyopathy | 0.79074743 |
| 112 | MP0002277_abnormal_respiratory_mucosa | 0.76674307 |
| 113 | MP0002295_abnormal_pulmonary_circulatio | 0.76252413 |
| 114 | MP0008872_abnormal_physiological_respon | 0.76080933 |
| 115 | MP0002019_abnormal_tumor_incidence | 0.76010662 |
| 116 | MP0005367_renal/urinary_system_phenotyp | 0.75630078 |
| 117 | MP0000516_abnormal_urinary_system | 0.75630078 |
| 118 | MP0001119_abnormal_female_reproductive | 0.74899578 |
| 119 | MP0001929_abnormal_gametogenesis | 0.74870082 |
| 120 | MP0000689_abnormal_spleen_morphology | 0.74452974 |
| 121 | MP0008775_abnormal_heart_ventricle | 0.74162078 |
| 122 | MP0001486_abnormal_startle_reflex | 0.73843866 |
| 123 | MP0002095_abnormal_skin_pigmentation | 0.72657476 |
| 124 | MP0003011_delayed_dark_adaptation | 0.72404559 |
| 125 | MP0003656_abnormal_erythrocyte_physiolo | 0.71297105 |
| 126 | MP0001145_abnormal_male_reproductive | 0.70621750 |
| 127 | MP0001727_abnormal_embryo_implantation | 0.70218725 |
| 128 | MP0002751_abnormal_autonomic_nervous | 0.69734170 |
| 129 | MP0001542_abnormal_bone_strength | 0.67488465 |
| 130 | MP0005646_abnormal_pituitary_gland | 0.67474040 |
| 131 | MP0003315_abnormal_perineum_morphology | 0.67243647 |
| 132 | MP0003121_genomic_imprinting | 0.67046368 |
| 133 | MP0000653_abnormal_sex_gland | 0.66818169 |
| 134 | MP0002127_abnormal_cardiovascular_syste | 0.66421379 |
| 135 | MP0002106_abnormal_muscle_physiology | 0.65751703 |
| 136 | MP0000350_abnormal_cell_proliferation | 0.64968240 |
| 137 | MP0005408_hypopigmentation | 0.64043945 |
| 138 | MP0002272_abnormal_nervous_system | 0.63941965 |
| 139 | MP0002938_white_spotting | 0.63732382 |
| 140 | MP0003724_increased_susceptibility_to | 0.63690332 |
| 141 | MP0004381_abnormal_hair_follicle | 0.63110223 |
| 142 | MP0003763_abnormal_thymus_physiology | 0.62348973 |
| 143 | MP0002398_abnormal_bone_marrow | 0.60793021 |
| 144 | MP0002722_abnormal_immune_system | 0.60000405 |
| 145 | MP0001440_abnormal_grooming_behavior | 0.59178861 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 6.02465043 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.69069500 |
| 3 | Mitochondrial inheritance (HP:0001427) | 5.54451475 |
| 4 | Hepatocellular necrosis (HP:0001404) | 5.31698565 |
| 5 | Increased CSF lactate (HP:0002490) | 5.07110251 |
| 6 | Acute encephalopathy (HP:0006846) | 4.93651319 |
| 7 | Hepatic necrosis (HP:0002605) | 4.84794518 |
| 8 | Progressive macrocephaly (HP:0004481) | 4.84665031 |
| 9 | Increased hepatocellular lipid droplets (HP:0006565) | 4.27684647 |
| 10 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.98083465 |
| 11 | Lipid accumulation in hepatocytes (HP:0006561) | 3.90975836 |
| 12 | Increased serum lactate (HP:0002151) | 3.87810615 |
| 13 | 3-Methylglutaconic aciduria (HP:0003535) | 3.87172841 |
| 14 | Increased serum pyruvate (HP:0003542) | 3.81122753 |
| 15 | Abnormality of glycolysis (HP:0004366) | 3.81122753 |
| 16 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.75542149 |
| 17 | Cerebral edema (HP:0002181) | 3.65355838 |
| 18 | Exercise intolerance (HP:0003546) | 3.64088338 |
| 19 | * Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.57864694 |
| 20 | * Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.57864694 |
| 21 | * Lactic acidosis (HP:0003128) | 3.57783285 |
| 22 | Renal Fanconi syndrome (HP:0001994) | 3.54398911 |
| 23 | Birth length less than 3rd percentile (HP:0003561) | 3.49199680 |
| 24 | Microvesicular hepatic steatosis (HP:0001414) | 3.43486271 |
| 25 | Increased intramyocellular lipid droplets (HP:0012240) | 3.38848522 |
| 26 | * Respiratory failure (HP:0002878) | 3.31976025 |
| 27 | Methylmalonic acidemia (HP:0002912) | 3.24314507 |
| 28 | Exertional dyspnea (HP:0002875) | 3.23058681 |
| 29 | Cerebral hypomyelination (HP:0006808) | 3.03362775 |
| 30 | Increased muscle lipid content (HP:0009058) | 2.97382711 |
| 31 | Optic disc pallor (HP:0000543) | 2.97200383 |
| 32 | Reticulocytopenia (HP:0001896) | 2.91334213 |
| 33 | Respiratory difficulties (HP:0002880) | 2.85974584 |
| 34 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.82475925 |
| 35 | Leukodystrophy (HP:0002415) | 2.82287907 |
| 36 | Abnormal number of erythroid precursors (HP:0012131) | 2.81038071 |
| 37 | Type I transferrin isoform profile (HP:0003642) | 2.77481323 |
| 38 | Hypoglycemic coma (HP:0001325) | 2.74434774 |
| 39 | Aplastic anemia (HP:0001915) | 2.72700431 |
| 40 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.69474178 |
| 41 | Abnormality of alanine metabolism (HP:0010916) | 2.69474178 |
| 42 | Hyperalaninemia (HP:0003348) | 2.69474178 |
| 43 | Colon cancer (HP:0003003) | 2.65578999 |
| 44 | CNS demyelination (HP:0007305) | 2.64582766 |
| 45 | Type 2 muscle fiber atrophy (HP:0003554) | 2.57880788 |
| 46 | Hypothermia (HP:0002045) | 2.56222200 |
| 47 | Molar tooth sign on MRI (HP:0002419) | 2.53917631 |
| 48 | Abnormality of midbrain morphology (HP:0002418) | 2.53917631 |
| 49 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.44953374 |
| 50 | Chromsome breakage (HP:0040012) | 2.40688263 |
| 51 | Emotional lability (HP:0000712) | 2.37527605 |
| 52 | Hyperglycinemia (HP:0002154) | 2.36894431 |
| 53 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.36727245 |
| 54 | Hypoglycemic seizures (HP:0002173) | 2.35378757 |
| 55 | Generalized aminoaciduria (HP:0002909) | 2.30835797 |
| 56 | Carpal bone hypoplasia (HP:0001498) | 2.26791985 |
| 57 | Exercise-induced muscle cramps (HP:0003710) | 2.26732539 |
| 58 | Muscle fiber atrophy (HP:0100295) | 2.25958876 |
| 59 | Nemaline bodies (HP:0003798) | 2.20200356 |
| 60 | Breast hypoplasia (HP:0003187) | 2.20197383 |
| 61 | Abnormality of renal resorption (HP:0011038) | 2.19087209 |
| 62 | Oral leukoplakia (HP:0002745) | 2.15024229 |
| 63 | X-linked dominant inheritance (HP:0001423) | 2.14043006 |
| 64 | Pancreatic fibrosis (HP:0100732) | 2.12823472 |
| 65 | Abnormality of vitamin B metabolism (HP:0004340) | 2.11837475 |
| 66 | Abnormality of placental membranes (HP:0011409) | 2.10619716 |
| 67 | Amniotic constriction ring (HP:0009775) | 2.10619716 |
| 68 | * Lethargy (HP:0001254) | 2.10503913 |
| 69 | Abnormality of serum amino acid levels (HP:0003112) | 2.10130317 |
| 70 | Muscle fiber inclusion bodies (HP:0100299) | 2.09267008 |
| 71 | Gait imbalance (HP:0002141) | 2.07482897 |
| 72 | Macrocytic anemia (HP:0001972) | 2.06526706 |
| 73 | Abnormality of the preputium (HP:0100587) | 2.04391292 |
| 74 | Hypoplasia of the fovea (HP:0007750) | 2.03212918 |
| 75 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.03212918 |
| 76 | Abnormal hair whorl (HP:0010721) | 2.01292065 |
| 77 | Nephronophthisis (HP:0000090) | 2.01288807 |
| 78 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.99943361 |
| 79 | Duplicated collecting system (HP:0000081) | 1.99679390 |
| 80 | Abnormality of methionine metabolism (HP:0010901) | 1.99173236 |
| 81 | Renal cortical cysts (HP:0000803) | 1.97690845 |
| 82 | Medial flaring of the eyebrow (HP:0010747) | 1.94437941 |
| 83 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.93731351 |
| 84 | Abnormality of the fovea (HP:0000493) | 1.92089264 |
| 85 | Neuroendocrine neoplasm (HP:0100634) | 1.91347851 |
| 86 | Pallor (HP:0000980) | 1.90927897 |
| 87 | Unsteady gait (HP:0002317) | 1.90527704 |
| 88 | Pancreatic cysts (HP:0001737) | 1.89298040 |
| 89 | Pancytopenia (HP:0001876) | 1.88417755 |
| 90 | Neoplasm of the adrenal gland (HP:0100631) | 1.87658808 |
| 91 | True hermaphroditism (HP:0010459) | 1.87167381 |
| 92 | Gliosis (HP:0002171) | 1.86829566 |
| 93 | Delayed gross motor development (HP:0002194) | 1.84706636 |
| 94 | Ragged-red muscle fibers (HP:0003200) | 1.84631594 |
| 95 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.83978982 |
| 96 | Hyperglycinuria (HP:0003108) | 1.83637378 |
| 97 | Megaloblastic anemia (HP:0001889) | 1.83137508 |
| 98 | Glycosuria (HP:0003076) | 1.82759719 |
| 99 | Abnormality of urine glucose concentration (HP:0011016) | 1.82759719 |
| 100 | Nephrogenic diabetes insipidus (HP:0009806) | 1.82008172 |
| 101 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.81992901 |
| 102 | Dicarboxylic aciduria (HP:0003215) | 1.81992901 |
| 103 | IgM deficiency (HP:0002850) | 1.81604021 |
| 104 | Methylmalonic aciduria (HP:0012120) | 1.81576167 |
| 105 | Agnosia (HP:0010524) | 1.80637530 |
| 106 | Hyperphosphaturia (HP:0003109) | 1.79951360 |
| 107 | Abnormality of the renal collecting system (HP:0004742) | 1.79934269 |
| 108 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.79683317 |
| 109 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.79620234 |
| 110 | Intestinal atresia (HP:0011100) | 1.79556233 |
| 111 | Rimmed vacuoles (HP:0003805) | 1.79302434 |
| 112 | Progressive external ophthalmoplegia (HP:0000590) | 1.79234104 |
| 113 | CNS hypomyelination (HP:0003429) | 1.78868550 |
| 114 | Palpitations (HP:0001962) | 1.78397098 |
| 115 | Abnormality of glycine metabolism (HP:0010895) | 1.77723275 |
| 116 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.77723275 |
| 117 | Reduced antithrombin III activity (HP:0001976) | 1.76607049 |
| 118 | Meckel diverticulum (HP:0002245) | 1.74990835 |
| 119 | Progressive inability to walk (HP:0002505) | 1.74253947 |
| 120 | Abnormality of the ileum (HP:0001549) | 1.73123819 |
| 121 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.72989366 |
| 122 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.72908346 |
| 123 | Congenital primary aphakia (HP:0007707) | 1.72349774 |
| 124 | Degeneration of anterior horn cells (HP:0002398) | 1.72144561 |
| 125 | Abnormality of the anterior horn cell (HP:0006802) | 1.72144561 |
| 126 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.71304716 |
| 127 | Abnormality of the labia minora (HP:0012880) | 1.71069358 |
| 128 | Genital tract atresia (HP:0001827) | 1.70799720 |
| 129 | Ketoacidosis (HP:0001993) | 1.70743024 |
| 130 | Nausea (HP:0002018) | 1.69345416 |
| 131 | Double outlet right ventricle (HP:0001719) | 1.66947548 |
| 132 | Congenital malformation of the right heart (HP:0011723) | 1.66947548 |
| 133 | Median cleft lip (HP:0000161) | 1.66604255 |
| 134 | Neoplasm of head and neck (HP:0012288) | 1.66432233 |
| 135 | Esophageal neoplasm (HP:0100751) | 1.66432233 |
| 136 | Blindness (HP:0000618) | 1.66060466 |
| 137 | Poor suck (HP:0002033) | 1.65929749 |
| 138 | Absent thumb (HP:0009777) | 1.65696261 |
| 139 | Abolished electroretinogram (ERG) (HP:0000550) | 1.65646989 |
| 140 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.64632154 |
| 141 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.64632154 |
| 142 | Abnormal protein glycosylation (HP:0012346) | 1.64632154 |
| 143 | Abnormal glycosylation (HP:0012345) | 1.64632154 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK16 | 3.91419854 |
| 2 | BUB1 | 3.43753276 |
| 3 | VRK2 | 3.09659991 |
| 4 | WEE1 | 2.90026671 |
| 5 | MAP3K12 | 2.85420854 |
| 6 | NME2 | 2.79099598 |
| 7 | TRIM28 | 2.78045585 |
| 8 | EIF2AK1 | 2.57463733 |
| 9 | VRK1 | 2.48909658 |
| 10 | NME1 | 2.41983653 |
| 11 | FRK | 2.38155492 |
| 12 | EIF2AK3 | 2.22429194 |
| 13 | ARAF | 2.22398482 |
| 14 | WNK3 | 2.22064222 |
| 15 | TSSK6 | 2.21945327 |
| 16 | CASK | 2.07489425 |
| 17 | PIM2 | 2.00685634 |
| 18 | CDC7 | 1.92533251 |
| 19 | MAP4K2 | 1.92174395 |
| 20 | NUAK1 | 1.90799778 |
| 21 | SRPK1 | 1.90635897 |
| 22 | CDK8 | 1.90316052 |
| 23 | MUSK | 1.80574484 |
| 24 | MYLK | 1.70049875 |
| 25 | PHKG1 | 1.69950849 |
| 26 | PHKG2 | 1.69950849 |
| 27 | PLK4 | 1.69585564 |
| 28 | CCNB1 | 1.59881235 |
| 29 | PBK | 1.58107952 |
| 30 | BRAF | 1.56400414 |
| 31 | ZAK | 1.52248751 |
| 32 | MAP3K4 | 1.51617363 |
| 33 | GRK1 | 1.48913425 |
| 34 | CSNK1G1 | 1.46938731 |
| 35 | GRK7 | 1.46879658 |
| 36 | NEK1 | 1.42560380 |
| 37 | AKT3 | 1.30286136 |
| 38 | STK39 | 1.28168940 |
| 39 | BMPR1B | 1.27110263 |
| 40 | ADRBK2 | 1.25481841 |
| 41 | CSNK1G2 | 1.23861787 |
| 42 | BCKDK | 1.22819898 |
| 43 | BRSK2 | 1.19701360 |
| 44 | PLK1 | 1.19653724 |
| 45 | INSRR | 1.15748576 |
| 46 | PDK4 | 1.15485519 |
| 47 | PDK3 | 1.15485519 |
| 48 | ERBB3 | 1.15128618 |
| 49 | PLK3 | 1.13748057 |
| 50 | MAP2K7 | 1.10680744 |
| 51 | TNIK | 1.07521983 |
| 52 | EIF2AK2 | 1.07465037 |
| 53 | IRAK4 | 1.06623156 |
| 54 | PDK2 | 1.06533190 |
| 55 | MKNK1 | 1.06401654 |
| 56 | SIK3 | 1.03094614 |
| 57 | CSNK1A1L | 1.01601260 |
| 58 | DAPK1 | 0.99737488 |
| 59 | BMPR2 | 0.98943201 |
| 60 | MAPKAPK5 | 0.98334358 |
| 61 | TESK2 | 0.98192347 |
| 62 | TAF1 | 0.96663652 |
| 63 | MST4 | 0.96589131 |
| 64 | MKNK2 | 0.94121659 |
| 65 | OXSR1 | 0.91828519 |
| 66 | DYRK2 | 0.91288738 |
| 67 | MAPKAPK3 | 0.91047428 |
| 68 | PAK3 | 0.90431326 |
| 69 | AURKA | 0.89076204 |
| 70 | OBSCN | 0.88517734 |
| 71 | ACVR1B | 0.88363666 |
| 72 | CDK19 | 0.86482393 |
| 73 | YES1 | 0.84382695 |
| 74 | GRK5 | 0.83540544 |
| 75 | TLK1 | 0.82459407 |
| 76 | STK24 | 0.82108974 |
| 77 | RPS6KB2 | 0.79420016 |
| 78 | CDK7 | 0.79369298 |
| 79 | PRKCE | 0.78974282 |
| 80 | TXK | 0.77052441 |
| 81 | WNK4 | 0.76736796 |
| 82 | TTK | 0.75005879 |
| 83 | PRKCG | 0.74281315 |
| 84 | CSNK2A1 | 0.73905382 |
| 85 | STK38L | 0.71783728 |
| 86 | IRAK3 | 0.70588959 |
| 87 | ATR | 0.70004251 |
| 88 | SCYL2 | 0.69357731 |
| 89 | PLK2 | 0.68583906 |
| 90 | MAPK13 | 0.68116305 |
| 91 | ABL2 | 0.67633985 |
| 92 | TIE1 | 0.66951949 |
| 93 | MINK1 | 0.65810697 |
| 94 | MARK1 | 0.64856941 |
| 95 | TEC | 0.64333637 |
| 96 | BRSK1 | 0.62989910 |
| 97 | AURKB | 0.62934535 |
| 98 | CSNK2A2 | 0.60154375 |
| 99 | BLK | 0.59239561 |
| 100 | MAP3K11 | 0.57080030 |
| 101 | RPS6KA5 | 0.56201517 |
| 102 | PRKG2 | 0.56103172 |
| 103 | KIT | 0.55761348 |
| 104 | CHEK2 | 0.55674130 |
| 105 | PINK1 | 0.55378340 |
| 106 | FLT3 | 0.54291504 |
| 107 | CAMK2A | 0.52442675 |
| 108 | PNCK | 0.49470925 |
| 109 | ILK | 0.48731738 |
| 110 | CSNK1G3 | 0.48117467 |
| 111 | LIMK1 | 0.47653449 |
| 112 | PIM1 | 0.46593359 |
| 113 | CSNK1A1 | 0.46224678 |
| 114 | MOS | 0.45051601 |
| 115 | CAMK2D | 0.44583485 |
| 116 | PRKACA | 0.44518510 |
| 117 | DYRK3 | 0.44271954 |
| 118 | DAPK3 | 0.43841555 |
| 119 | NEK9 | 0.43394055 |
| 120 | RPS6KA6 | 0.43134232 |
| 121 | PRKG1 | 0.42738269 |
| 122 | CAMKK2 | 0.41059774 |
| 123 | TRPM7 | 0.39468781 |
| 124 | NLK | 0.39276440 |
| 125 | STK4 | 0.39171397 |
| 126 | EPHA2 | 0.38593462 |
| 127 | TESK1 | 0.36910354 |
| 128 | ATM | 0.36782404 |
| 129 | TGFBR1 | 0.36291290 |
| 130 | PRKCI | 0.35919932 |
| 131 | SYK | 0.34891739 |
| 132 | MAP2K6 | 0.34799003 |
| 133 | PAK1 | 0.34563366 |
| 134 | EPHA4 | 0.34021997 |
| 135 | IKBKB | 0.33538838 |
| 136 | MAP4K1 | 0.32960051 |
| 137 | MAP3K6 | 0.32335106 |
| 138 | BCR | 0.32130649 |
| 139 | LYN | 0.31034287 |
| 140 | ADRBK1 | 0.30672419 |
| 141 | MATK | 0.30067102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.42934881 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.26558747 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.76227134 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.72853344 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 3.70616531 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 3.11337313 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 3.07820683 |
| 8 | Huntingtons disease_Homo sapiens_hsa05016 | 2.83341470 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.55702350 |
| 10 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.50260502 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.41286549 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 2.30795613 |
| 13 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.23822194 |
| 14 | Protein export_Homo sapiens_hsa03060 | 2.20608602 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.15412032 |
| 16 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.14137509 |
| 17 | Base excision repair_Homo sapiens_hsa03410 | 2.06993328 |
| 18 | Spliceosome_Homo sapiens_hsa03040 | 1.93811168 |
| 19 | Basal transcription factors_Homo sapiens_hsa03022 | 1.86774244 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.66788402 |
| 21 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.64210585 |
| 22 | RNA transport_Homo sapiens_hsa03013 | 1.62858284 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.54524145 |
| 24 | Purine metabolism_Homo sapiens_hsa00230 | 1.53434609 |
| 25 | RNA degradation_Homo sapiens_hsa03018 | 1.49187478 |
| 26 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.45363199 |
| 27 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.40528965 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.34281984 |
| 29 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.33209426 |
| 30 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.31947989 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.29732825 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.24658332 |
| 33 | Cell cycle_Homo sapiens_hsa04110 | 1.21158357 |
| 34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.20813950 |
| 35 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.19105566 |
| 36 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18667440 |
| 37 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.14745251 |
| 38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.13370583 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.12747801 |
| 40 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.11830227 |
| 41 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.08334654 |
| 42 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.08174695 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.06899795 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.95290267 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.94527234 |
| 46 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.93350102 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 0.92919271 |
| 48 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.92136113 |
| 49 | Metabolic pathways_Homo sapiens_hsa01100 | 0.86927916 |
| 50 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.85837144 |
| 51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.83053429 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83025218 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.79554670 |
| 54 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.78733685 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78649852 |
| 56 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.78434846 |
| 57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.78275095 |
| 58 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.77992043 |
| 59 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.77032305 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75406172 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74594778 |
| 62 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72341166 |
| 63 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72246684 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70852349 |
| 65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.69051416 |
| 66 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.67303258 |
| 67 | Retinol metabolism_Homo sapiens_hsa00830 | 0.61965300 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.61756040 |
| 69 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.61365016 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.61237956 |
| 71 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60476022 |
| 72 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.60200601 |
| 73 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.59743744 |
| 74 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58568284 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57915520 |
| 76 | Phototransduction_Homo sapiens_hsa04744 | 0.54722059 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.54573396 |
| 78 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.54105014 |
| 79 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53892516 |
| 80 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.52128688 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51773622 |
| 82 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49383976 |
| 83 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.48623683 |
| 84 | Peroxisome_Homo sapiens_hsa04146 | 0.47928688 |
| 85 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.46103777 |
| 86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45973089 |
| 87 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.44670282 |
| 88 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.43646053 |
| 89 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.43069336 |
| 90 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42583744 |
| 91 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.41181878 |
| 92 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.41096882 |
| 93 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37673949 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.36703326 |
| 95 | Legionellosis_Homo sapiens_hsa05134 | 0.35467520 |
| 96 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.33943495 |
| 97 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.33560033 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33525596 |
| 99 | Insulin secretion_Homo sapiens_hsa04911 | 0.32866841 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32169438 |
| 101 | GABAergic synapse_Homo sapiens_hsa04727 | 0.31462511 |
| 102 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30890620 |
| 103 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.29869074 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28073801 |
| 105 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.27390950 |
| 106 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.26805551 |
| 107 | Phagosome_Homo sapiens_hsa04145 | 0.26005154 |
| 108 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.25028998 |
| 109 | Sulfur relay system_Homo sapiens_hsa04122 | 0.23483233 |
| 110 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.22065443 |
| 111 | Asthma_Homo sapiens_hsa05310 | 0.20863492 |
| 112 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.20477524 |
| 113 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.20007086 |
| 114 | Allograft rejection_Homo sapiens_hsa05330 | 0.18910920 |
| 115 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.17715546 |
| 116 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.17500550 |
| 117 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.16385440 |
| 118 | Histidine metabolism_Homo sapiens_hsa00340 | 0.14660234 |
| 119 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.13565657 |
| 120 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.12905874 |
| 121 | Nicotine addiction_Homo sapiens_hsa05033 | 0.12854028 |
| 122 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.12787517 |
| 123 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.12786691 |
| 124 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.12036962 |
| 125 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.12026488 |
| 126 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.11039305 |
| 127 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.10355025 |

